- Telehealth Visits
- Insurance plan information
Jacqueline Desjardin, MD
She | Her | HersCardiology (Heart Failure and Transplant) • Cardiology- Telehealth Visits
- Insurance plan information
Jacqueline Desjardin, MD
She | Her | HersCardiology (Heart Failure and Transplant) • Cardiology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Jacqueline DesJardin is a cardiologist who cares for patients experiencing heart failure and pulmonary hypertension (a serious disorder affecting the lung's blood vessels). Her treatment expertise includes use of mechanical circulatory support (devices that help the heart function or heal) and heart transplantation.
In her research, DesJardin is focused on improving diagnosis and treatment of heart failure and pulmonary hypertension.
At UCSF, DesJardin earned her medical degree, completed a residency in internal medicine, and completed fellowships in cardiology and advanced heart failure. She also has a master of advanced studies degree in clinical and epidemiological research from UCSF.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Advanced Heart Failure and Transplant Cardiology, UCSF School of Medicine -GME
- Cardiovascular Disease, UCSF School of Medicine -GME
Residency
- Internal Medicine, UCSF School of Medicine -GME
Internship
- Internal Medicine, UCSF School of Medicine -GME
Degree
- MD, UCSF School of Medicine
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
- Cardiology (Heart Failure and Transplant)
- Cardiology
Conditions
Treatments
- Mechanical Circulatory Support
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.